Conference - Boston, United States
Epigenetic drug discovery is exploding across the industry
And EpiCongress will place you right at the heart of the action…
With more epigenetics focused companies than anywhere else, the epicenter for epigenetic drug developers is returning to Boston this July 23 - 26.
The meeting has been designed in collaboration with thought leaders at GSK, EpiZyme, Constellation, Pfizer, Genentech, Celgene, Abbvie, Gilead, Acetylon, and many more. EpiCongress will not only help you to understand the basic mechanisms behind genome regulation and chromatin function. It will also address the most pressing clinical considerations to ensure the success of current and future candidates.
Hear from 50 expert speakers from across pharma, biotechs and research institutes presenting their most promising data. Capture the last 12 months of progress by hearing how epigenetic candidates have been performing across the board. And access the translational science with the potential to transform your drug discovery.
(Courtesy of logo of EpiCongress Boston, via nature.com)
23rd - 26th July 2013
DoubleTree Suites by Hilton Hotel Boston
400 Soldiers Field Road, Boston, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
